Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Toyota Motor Corp — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.18 (market cap $12.58B), while Toyota Motor Corp trades at $184.76 (market cap $217.38B). The key difference: Toyota Motor Corp is far larger — about 17.3× Halozyme Therapeutics Inc. Common Stock's market cap, and Toyota Motor Corp pays a 3.37% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Toyota Motor Corp for 116 Days on average.
| HALO | TM | |
|---|---|---|
Market Cap | $12.58B | $217.38B |
Volume | 2,179,278 | 291,250 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $248.29 |
52-Week Low | $61.63 | $166.50 |
Typical Hold Time | 0 Days | 116 Days |
Enterprise Value | $14.49B | $410.96B |
Dividend Yield | — | 3.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Toyota Motor trades at $185.17, up 1.24% with a bearish technical signal despite strong fundamentals. The stock shows attractive valuation metrics with a P/E of 8.38 and P/S of 0.73, while delivering consistent earnings beats in recent quarters. Recent news highlights strong U.S. sales performance and electrification progress, though technical indicators show selling pressure with key support at $184.
Toyota presents a value opportunity with solid profitability and clean balance sheet, though near-term headwinds include China sales weakness and production disruptions. Analyst consensus leans cautious with 62.5% hold ratings, reflecting concerns about profit margin compression despite the company's market leadership and electrification investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
